Aldose reductase inhibition counteracts oxidative-nitrosative stress and poly(ADP-ribose) polymerase activation in tissue sites for diabetes complications.
about
Nitric oxide and peroxynitrite in health and diseaseTherapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinolRole of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategiesPotential Bioactive Compounds from Seaweed for Diabetes ManagementMolecular mechanisms of diabetic retinopathy, general preventive strategies, and novel therapeutic targetsMitochondrial stress and the pathogenesis of diabetic neuropathyNutrient excess and altered mitochondrial proteome and function contribute to neurodegeneration in diabetesDeletion of aldose reductase from mice inhibits diabetes-induced retinal capillary degeneration and superoxide generationElevated protein carbonylation, and misfolding in sciatic nerve from db/db and Sod1(-/-) mice: plausible link between oxidative stress and demyelinationRetinal insulin receptor signaling in hyperosmotic stressTransforming growth factor-beta induces cellular injury in experimental diabetic neuropathySchwann cell interactions with axons and microvessels in diabetic neuropathy.Hyperglycemia alters the schwann cell mitochondrial proteome and decreases coupled respiration in the absence of superoxide production.PGC-1α regulation of mitochondrial degeneration in experimental diabetic neuropathy.Phospho-Site-Specific Antibody Microarray to Study the State of Protein Phosphorylation in the Retina.Mitochondrial respiratory chain dysfunction in dorsal root ganglia of streptozotocin-induced diabetic rats and its correction by insulin treatmentHigh-fat diet-induced neuropathy of prediabetes and obesity: effect of PMI-5011, an ethanolic extract of Artemisia dracunculus LMetabolome and proteome changes with aging in Caenorhabditis elegans.Amelioration of acute kidney injury in lipopolysaccharide-induced systemic inflammatory response syndrome by an aldose reductase inhibitor, fidarestat.Peroxynitrite and protein nitration in the pathogenesis of diabetic peripheral neuropathy.Peroxynitrite-driven mechanisms in diabetes and insulin resistance - the latest advancesCardiomyocyte aldose reductase causes heart failure and impairs recovery from ischemia.Evaluation of the aldose reductase inhibitor fidarestat on ischemia-reperfusion injury in rat retina.Role of 12/15-lipoxygenase in nitrosative stress and peripheral prediabetic and diabetic neuropathiesNitrosylated proteins in monocytes as a new marker of oxidative-nitrosative stress in diabetic subjects with macroangiopathy.Phenotypic changes in diabetic neuropathy induced by a high-fat diet in diabetic C57BL/6 mice.Tyrosine nitration of prostacyclin synthase is associated with enhanced retinal cell apoptosis in diabetes.Taurine reduces nitrosative stress and nitric oxide synthase expression in high glucose-exposed human Schwann cells.Interplay of sorbitol pathway of glucose metabolism, 12/15-lipoxygenase, and mitogen-activated protein kinases in the pathogenesis of diabetic peripheral neuropathyAldose reductase, oxidative stress, and diabetic mellitus.Bioactivity Focus of α-Cyano-4-hydroxycinnamic acid (CHCA) Leads to Effective Multifunctional Aldose Reductase Inhibitors.Role of poly(ADP-ribose) polymerase-1 activation in the pathogenesis of diabetic complications: endothelial dysfunction, as a common underlying theme.Role of peroxynitrite in the pathogenesis of cardiovascular complications of diabetes.A peroxynitrite decomposition catalyst counteracts sensory neuropathy in streptozotocin-diabetic mice.Aldose reductase inhibition counteracts nitrosative stress and poly(ADP-ribose) polymerase activation in diabetic rat kidney and high-glucose-exposed human mesangial cells.Early diabetes-induced biochemical changes in the retina: comparison of rat and mouse models.Poly(ADP-ribose) polymerase inhibition alleviates experimental diabetic sensory neuropathyOxidative-nitrosative stress and poly(ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy: the relation is revisited.Therapeutic applications of PARP inhibitors: anticancer therapy and beyondEvaluation of the peroxynitrite decomposition catalyst Fe(III) tetra-mesitylporphyrin octasulfonate on peripheral neuropathy in a mouse model of type 1 diabetes.
P2860
Q24645400-23ACE05D-78F1-4D4F-9C6E-24B8DAB6C506Q24652967-90C06118-CCA4-4DE7-9F2A-5AA731D65B15Q24656109-C0C2A2E1-DD6D-42A4-9547-A23B89301589Q26797339-85DD14E7-4F63-4BE9-919D-E81149AE8287Q27014620-A161FDC1-2363-4348-9097-4F7A24F03D46Q28382887-7E3AFEB6-6B91-453E-B23D-EF7865878141Q28385506-4377EE21-2A92-47F9-B42B-EAB2A9D2AAF3Q28486203-42BDB38C-BFB1-43DC-B379-EF8DB0A82985Q28533621-A23E7462-4F4B-4DF7-8564-93B2E3DE4422Q28568662-496099FF-D1F0-453F-9805-4C2458326312Q28575618-18AF14A2-8AC0-4E80-B75E-DDDB7559579DQ30238727-6FEAD14F-0CCC-4A6B-9D34-2462E440AFDFQ33571909-15D78C66-65BC-4A87-9AF1-B9A8701AF0C0Q33623182-CF521BD0-EB38-41BD-94F2-4D3AF16D4BFCQ33642984-1145720A-FE00-4758-8874-EFCF897647E8Q33750650-0A43BF0A-0CE6-4EEC-9251-C05C55941FD9Q33781251-37A615F6-4DA3-4138-B0DA-9877BA6DB080Q33807271-B98B9470-69C3-4A60-88D6-5DBB06AB1B6AQ34131121-17BB3F59-D64E-4EAF-86A4-80AC814A68B9Q34257700-B9D6BB3F-90E8-4C91-B145-A6AE2B8AF481Q34314724-FA898E10-EAB5-423B-B39A-E1959B02BC63Q34431401-B09F84F3-CC94-4177-B87E-BACC86D0371DQ34603008-20D7D3CD-1A76-4ACE-9DBC-7C3BBD118FF6Q34667363-FD61BD77-1A7C-49C9-805D-02867C6A262CQ34670046-C071879B-8FC5-4DF6-BF9C-4E7662D18163Q35579658-9A6A5B26-0BB0-4115-B725-628D7CA3B884Q35679391-68ABC934-47BE-4C0E-835F-1F0060208285Q35713992-A7F226EB-14F1-4F2E-A151-D3FF90C95270Q35784340-2A4768AA-8E1E-408D-831C-B181471D4785Q35947855-E0315494-01C9-4888-99B1-14D4B287C325Q35997820-580A52A4-449F-45BC-A15A-6716195CAA4AQ36342643-D0C2E356-625C-4E9C-967D-70F15FFF47C7Q36398989-AD3ED126-6543-4CD3-A4E2-20DABACAA2EBQ36426801-5FAF8C54-AB58-42D4-9EF9-16E9926B522DQ36426843-7678CC4C-5E34-4D26-96EC-5B848EDDE7B7Q36431788-3F4346BF-DAA9-4D4E-87DC-13F3F2FE60E9Q36431822-5704292B-52F6-4319-AE0F-6CC3DB047E5FQ36431827-D359A20E-869A-4933-9971-3C2452D4BD7BQ36853236-4E8C3985-7774-445B-B892-4176659CCA56Q36857402-BF3240FF-09A1-47F1-9353-377DAC0C1E0A
P2860
Aldose reductase inhibition counteracts oxidative-nitrosative stress and poly(ADP-ribose) polymerase activation in tissue sites for diabetes complications.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2005
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Aldose reductase inhibition counteracts oxidative-nitrosative stress and poly
@nl
Aldose reductase inhibition co ...... es for diabetes complications.
@en
type
label
Aldose reductase inhibition counteracts oxidative-nitrosative stress and poly
@nl
Aldose reductase inhibition co ...... es for diabetes complications.
@en
prefLabel
Aldose reductase inhibition counteracts oxidative-nitrosative stress and poly
@nl
Aldose reductase inhibition co ...... es for diabetes complications.
@en
P2093
P2860
P50
P1433
P1476
Aldose reductase inhibition co ...... es for diabetes complications.
@en
P2093
Csaba Szabó
Hiroko Hirooka
Irina G Obrosova
Martin J Stevens
P2860
P304
P356
10.2337/DIABETES.54.1.234
P407
P577
2005-01-01T00:00:00Z